BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ: OCUL) announced today the pricing of an underwritten public offering of 4,000,000 shares of its common stock at a public offering price of $22.00 per share, before underwriting discounts. The offering consists of 3,200,000 shares being sold by the Company and 800,000 shares being sold by certain stockholders of the Company. In addition, the selling stockholders have granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional 600,000 shares of the Company’s common stock at the public offering price, less the underwriting discount. Ocular Therapeutix will not receive any proceeds from the sale of shares by the selling stockholders.
Help employers find you! Check out all the jobs and post your resume.
